WLCGF (Welcia Holdings Co) ROE %: 15.17% (As of Aug. 2025) — 17% Above Median


WLCGF Welcia Holdings Co Ltd WLCGF
18 GF Score
Price $16.41
GF Value $14.20
! 6 Warning Signs
View Full Analysis

What is Welcia Holdings Co ROE %?

Welcia Holdings Co WLCGF 18 ROE % is 15.17% as of Aug. 2025, which is 17% above its 10-year median of 12.95. GuruFocus rates WLCGF with a GF Score™ of 18/100 and a GF Value™ of $14.20. The stock has 6 warning signs investors should review.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Welcia Holdings Co's annualized net income for the quarter that ended in Aug. 2025 was $266 Mil. Welcia Holdings Co's average Total Stockholders Equity over the quarter that ended in Aug. 2025 was $1,756 Mil. Therefore, Welcia Holdings Co's annualized ROE % for the quarter that ended in Aug. 2025 was 15.17%.

The historical rank and industry rank for Welcia Holdings Co's ROE % or its related term are showing as below:

WLCGF' s ROE % Range Over the Past 10 Years
Min: 6.15   Med: 12.95   Max: 16.39
Current: 7.62

During the past 13 years, Welcia Holdings Co's highest ROE % was 16.39%. The lowest was 6.15%. And the median was 12.95%.

WLCGF's ROE % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 5.72 vs WLCGF: 7.62

Welcia Holdings Co  (OTCPK:WLCGF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Aug. 2025 )
=Net Income/Total Stockholders Equity
=266.396/1756.317
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(266.396 / 9340.068)*(9340.068 / 4411.528)*(4411.528 / 1756.317)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.85 %*2.1172*2.5118
=ROA %*Equity Multiplier
=6.03 %*2.5118
=15.17 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Aug. 2025 )
=Net Income/Total Stockholders Equity
=266.396/1756.317
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (266.396 / 432.064) * (432.064 / 406.756) * (406.756 / 9340.068) * (9340.068 / 4411.528) * (4411.528 / 1756.317)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6166 * 1.0622 * 4.35 % * 2.1172 * 2.5118
=15.17 %

Note: The net income data used here is four times the quarterly (Aug. 2025) net income data. The Revenue data used here is four times the quarterly (Aug. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Welcia Holdings Co ROE % Related Terms


Welcia Holdings Co ROE % Historical Data

* Premium members only.

The historical data trend for Welcia Holdings Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Welcia Holdings Co ROE % Chart

Welcia Holdings Co Annual Data
Trend Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.73 13.28 11.78 10.76 6.11

Welcia Holdings Co Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.12 4.83 0.29 9.98 15.17

Welcia Holdings Co ROE % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Welcia Holdings Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Welcia Holdings Co ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Welcia Holdings Co's ROE % distribution charts can be found below:

* The bar in red indicates where Welcia Holdings Co's ROE % falls into.


WLCGF
18GF Score
Welcia Holdings Co Ltd WLCGF
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Welcia Holdings Co ROE % Calculation

Welcia Holdings Co's annualized ROE % for the fiscal year that ended in Feb. 2025 is calculated as

ROE %=Net Income (A: Feb. 2025 )/( (Total Stockholders Equity (A: Feb. 2024 )+Total Stockholders Equity (A: Feb. 2025 ))/ count )
=98.686/( (1588.811+1640.235)/ 2 )
=98.686/1614.523
=6.11 %

Welcia Holdings Co's annualized ROE % for the quarter that ended in Aug. 2025 is calculated as

ROE %=Net Income (Q: Aug. 2025 )/( (Total Stockholders Equity (Q: May. 2025 )+Total Stockholders Equity (Q: Aug. 2025 ))/ count )
=266.396/( (1735.42+1777.214)/ 2 )
=266.396/1756.317
=15.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Aug. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 15.17% mean?
Welcia Holdings Co (WLCGF) has a ROE % of 15.17% as of Aug. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Welcia Holdings Co and its competitors. This is 17% above median its historical median of 12.95. Over the past decade, Welcia Holdings Co's ROE % has ranged from 6.15 to 16.39.
Is Welcia Holdings Co's ROE % too high?
Welcia Holdings Co's current ROE % of 15.17% is 17% above median its 10-year median of 12.95. Over the past 10 years, this metric has ranged from a low of 6.15 to a high of 16.39. The Healthcare Providers & Services industry median ROE % is 5.72. Welcia Holdings Co's value of 15.17% is 165.2% above this industry median. Overall, Welcia Holdings Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Welcia Holdings Co's ROE % compare to competitors?
Welcia Holdings Co's ROE % of 15.17% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROE % is 5.72. Welcia Holdings Co's value of 15.17% is 165.2% above this benchmark. Historically, Welcia Holdings Co's own ROE % has ranged from 6.15 to 16.39 over the past decade. While the company's 10-year median is 12.95 vs. the industry median of 5.72, Welcia Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Welcia Holdings Co's current ROE % of 15.17% is 165.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Welcia Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcia Holdings Co's current ROE % is 15.17%, which is 17% above median its own 10-year median of 12.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcia Holdings Co stock overvalued right now?
Welcia Holdings Co (WLCGF) has a current ROE % of 15.17%. The stock's GF Value™ is $14.20, compared to a current price of $16.41 — trading 15.6% above its estimated fair value. The current ROE % is 15.17%, which is 17% above median its 10-year median of 12.95 and 165.2% above the Healthcare Providers & Services industry median of 5.72. Welcia Holdings Co's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Welcia Holdings Co (WLCGF), the current ROE % is 15.17% as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Welcia Holdings Co (WLCGF) Overvalued in 2026?

Based on GuruFocus' analysis, Welcia Holdings Co stock appears to be overvalued. The current stock price of $16.41 is trading 15.6% above its estimated GF Value™ of $14.20.

Key valuation signals for WLCGF:

  • ROE %: 15.17% (17% above median its 10-year median of 12.95)
  • GF Value™: $14.20 vs. price of $16.41 (15.6% above fair value)
  • GF Score™: 18/100 with 6 warning signs
  • Industry Position: 165.2% above the Healthcare Providers & Services median

No single metric tells the full story. See the WLCGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Welcia Holdings Co Business Description

Address 2-2-15 Outside Kanda, Chiyoda-ku, Tokyo, JPN, 101-0021
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.
18GF Score

Get the complete analysis for WLCGF

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.41
Price
$14.20
GF Value